Dosage & Administration
Adults :
1 tablespoonful twice a day
Children :
2 teaspoonful twice a day

Presentation
100ml and 200 ml bottle

Composition
Each 5ml contains aqueous extracts of:
Adulsa (Adhatoda vasaka) 200 mg
Tulsi (Ocimum sanctum) 100 mg
Kantakari (Solanum xanthocarpum) 100 mg
Behada (Terminalia belerica) 50 mg
Jeshtimadh (Glycyrrhizae glabra) 50 mg
Sunthi (Zingiber officinale) 25 mg
Navasara (Ammonium chloride) 25 mg
Kapur (Camphor) 0.5 mg
Peppermint 1 mg
References
1. Claeson, U.P. et al. (2000) Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J Ethnopharmacol 72: 1–20.
2. Dhuley J N.Antitussive effect of Adhatoda vasica extract on mechanical or chemical Stimulation-induced coughing in animals. Journal of Ethnopharmacology 67 (1999) 361–365
3. Cambridge, G.W., Jansen, A.B., and Jarman, D.A. (1962) Bronchodilating action of vasicinone and related compounds. Nature 196: 1217.
4. Gupta, O.P. and et al. (1977) Pharmacological investigations of vasicine and vasicinone-the alkaloids of Adhatoda vasica. Indian J Med Res 66: 690–691.
5. Prakash P & Gupta N.therapeutic uses of ocimum sanctum linn (tulsi) with a note on eugenol and its pharmacological actions: A short review Indian J Physiol Pharmacol 2005; 49 (2) :125–131
6. Pratibha D. Nadig & Laxmi S. Study of anti-tussive activity of Ocimum sanctum Linn in guinea pigs Indian J Physiol Pharmacol 2005; 49 (2) : 243–245.
7. Gupta SS, Gupta NK. Effect of Solanum xanthocarpum and Clerodendron serratum on histamine release from tissues. Indian J Med Sci. 1967 Dec;21(12):795-9.
8. Vadnere G P et al. Evaluation of anti-asthmatic property of Solanum xanthocarpum flower extracts. Pharmacologyonline 2008, 1: 513-522
9. Bector NP, Puri AS. Solanum xanthocarpum (Kantakari) in chronic bronchitis, bronchial asthma and non-specific unproductive cough. (An experimental and clinical co-relation). J Assoc Physicians India. 1971 Oct;19(10):741-4.
10. Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. J Ethnopharmacol. 1999 Aug;66(2):205-10.
11. Naik G H, Priyadarsini K I, Bhagirathi R G, Mishra B, Mishra K P, Banavalikar M M and Mohan H. In Vitro Antioxidant Studies and Free Radical Reactions of Triphala, an Ayurvedic Formulation and its Constituents Phytother. Res. 19, 582–586, 2005.
12. Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002 Jul;81(2):155-60.
13. Sabu MC, Kuttan R. Antidiabetic and antioxidant activity of Terminalia belerica. Roxb. Indian J Exp Biol. 2009 Apr;47(4):270-5.
14. Vyas B A, Vyas R B. Effect of ethanolic extracts of Allium sativum and Terminalia belerica on clonidine-induced mast cell degranulation and clonidine and haloperidol-induced catalepsy in mice. Int J Pharm Res (2009) 1(1) 41-44.
15. Kitagawa, I., Chen, W. Z., Hori, K., Harada, E., Yasuda, N., Yoshikawa, M., and Ren, J. Chemical studies of Chinese licorice-roots. I. Elucidation of five new flavonoid constituents from the roots of Glycyrrhiza glabra L. collected in Xinjiang. Chem Pharm Bull (Tokyo) 1994;42(5):1056-1062
16. Baker, M. E. and Fanestil, D. D. Licorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and prostaglandin action. Mol Cell Endocrinol. 1991;78(1-2):C99-102.
17. Dedov VN, Tran VH, Duke CC, Connor M, Christie MJ, Mandadi S, et al. Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol 2002;137:793–8
18. Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005;8:125–32.
19. Shen CL, Hong KJ, Kim SW. Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. J Med Food 2005;8:149–53.
20. M.L.B. Ahui et al. Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation International Immunopharmacology 8 (2008) 1626–1632.
21. Richardson PS, Phipps RJ. The anatomy, physiology, pharmacology and pathology of tracheobronchial mucus secretion and the use of expectorant drugs in human disease. Pharmacol Ther B 1978; 3:441-79
22.. Cough and cold remedies for the treatment of acute respiratory infections in young children. World Health Organization. Dept. of Child and Adolescent Health and Development, 2001
Explore Product
Categories
Products
Adulsa Plus Cough Syrup
Therapeutic Category : Anti-tussive Expectorant
Actions
  • Potent mucolytic
  • Quick liquefaction of phlegm
  • Enhanced muco-ciliary clearance
  • Instant soothing demulcent
  • Safe expectorant
  • Non-sedating & non-habit forming
     
Indications
  • Cough of varied etiologies (Kasa)
  • Bronchitis (Kasa roga)
  • Laryngitis (Galaugha)
  • Sinusitis (Pinasa)